drugset

drugset / Trial / NCT00302536

Tacrolimus Treatment of Patients With Idiopathic Focal Segmental Glomerulosclerosis

NCT00302536 ↗

Withdrawn Nanjing University School of Medicine

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the efficacy of Tacrolimus Treatment of patients with idiopathic focal segmental glomerulosclerosis.

Timeline

Start: 2006-03
Primary completion: 2010-05
Completion: 2010-09

Publications

Hodson EM, Sinha A, Cooper TE. Interventions for focal segmental glomerulosclerosis in adults. Cochrane Database Syst Rev. 2022 Feb 28;2(2):CD003233. doi: 10.1002/14651858.CD003233.pub3.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Tacrolimus	Small molecule	—	—

Indications